Insufficient scRNA-seq data for expression of LPO at single-cell level.
Insufficient scRNA-seq data for expression of LPO at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 82% | 21.94 | 2164 / 2642 | 1% | 0.01 | 7 / 705 |
spleen | 76% | 19.45 | 182 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 56% | 9.99 | 524 / 929 | 0% | 0 | 0 / 0 |
lung | 43% | 10.34 | 248 / 578 | 5% | 0.14 | 54 / 1155 |
ovary | 7% | 0.47 | 13 / 180 | 29% | 0.88 | 126 / 430 |
breast | 28% | 21.47 | 130 / 459 | 5% | 0.24 | 59 / 1118 |
skin | 25% | 3.00 | 450 / 1809 | 1% | 1.29 | 3 / 472 |
pancreas | 23% | 1.55 | 75 / 328 | 0% | 0 | 0 / 178 |
intestine | 15% | 1.63 | 147 / 966 | 6% | 0.17 | 30 / 527 |
esophagus | 16% | 13.90 | 224 / 1445 | 3% | 0.07 | 6 / 183 |
adrenal gland | 16% | 4.26 | 41 / 258 | 1% | 0.01 | 2 / 230 |
prostate | 17% | 1.07 | 41 / 245 | 0% | 0 | 0 / 502 |
kidney | 16% | 1.33 | 14 / 89 | 0% | 0.01 | 3 / 901 |
uterus | 13% | 1.94 | 22 / 170 | 3% | 0.07 | 12 / 459 |
liver | 13% | 1.00 | 30 / 226 | 1% | 0.09 | 6 / 406 |
stomach | 7% | 0.64 | 25 / 359 | 8% | 0.20 | 22 / 286 |
thymus | 14% | 1.00 | 92 / 653 | 0% | 0.01 | 1 / 605 |
adipose | 13% | 11.03 | 155 / 1204 | 0% | 0 | 0 / 0 |
bladder | 10% | 0.43 | 2 / 21 | 2% | 0.07 | 10 / 504 |
heart | 9% | 1.04 | 75 / 861 | 0% | 0 | 0 / 0 |
muscle | 6% | 0.90 | 45 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 5% | 0.69 | 67 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.08 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0018969 | Biological process | thiocyanate metabolic process |
GO_0042744 | Biological process | hydrogen peroxide catabolic process |
GO_0001580 | Biological process | detection of chemical stimulus involved in sensory perception of bitter taste |
GO_0098869 | Biological process | cellular oxidant detoxification |
GO_0006979 | Biological process | response to oxidative stress |
GO_0042742 | Biological process | defense response to bacterium |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0005737 | Cellular component | cytoplasm |
GO_0140825 | Molecular function | lactoperoxidase activity |
GO_0020037 | Molecular function | heme binding |
GO_0036393 | Molecular function | thiocyanate peroxidase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | LPO |
Protein name | Lactoperoxidase (LPO) (EC 1.11.1.7) (Salivary peroxidase) (SPO) Lactoperoxidase |
Synonyms | SAPX |
Description | FUNCTION: Heme-containing oxidoreductase which catalyzes the conversion of thiocyanate (SCN(-)) into antimicrobial agent hypothiocyanous acid (OSCN(-)) in the presence of hydrogen peroxide (H2O2) (By similarity). Also involved in the conversion of iodide (I(-)) into hypoiodite (IO(-)) in the presence of H2O2 (By similarity). Responsible for the inactivation of a wide range of micro-organisms and hence, important component of defense mechanism . Shows antibacterial properties against Pseudomonas aeruginosa . The lactoperoxidase-SCN(-)-H2O2 system shows antibacterial properties against Burkholderia cepacia and Haemophilus influenzae in vitro . Present in mammary and salivary gland secretions and may contribute to airway host defense against infection . May contribute to maintaining an appropriate H2O2 cellular level, therefore protecting cells from H2O2-caused injuries and inflammation (By similarity). . |
Accessions | F5H386 ENST00000543544.5 ENST00000262290.9 [P22079-1] ENST00000389576.4 H0Y3I2 ENST00000580890.5 ENST00000581008.1 J3KT11 J3QSD8 P22079 ENST00000582328.5 [P22079-2] ENST00000421678.6 [P22079-2] |